Influenza, human Trials in Austin, United States
Conditions / Influenza, human / Austin, United States
Influenza, human has been the subject of sustained clinical investigation across multiple research sites.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02214225 | A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above. | COMPLETED | PHASE3 |
| NCT05227001 | A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza | COMPLETED | PHASE1 |
| NCT06431607 | A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults | COMPLETED | PHASE2 |
| NCT07121192 | A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT02545543 | A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age | COMPLETED | PHASE3 |
| NCT03275389 | A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years | COMPLETED | PHASE1 |
| NCT02914275 | A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age. | COMPLETED | PHASE3 |
| NCT02867358 | A Clinical Trial of KT07 Capsule in the U.S.A | COMPLETED | PHASE2 |
| NCT06382311 | A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults | COMPLETED | PHASE1/PHASE2 |
| NCT05540522 | A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older | COMPLETED | PHASE3 |